Mathieu Peyrou graduated from the Ecole Nationale Veterinaire de Toulouse (ENVT) in 1999. After an internship at the Veterinary Faculty in St-Hyacinthe, QC, Canada, he undertook a MSc in Veterinary Pharmacology at the University of Montreal, followed by a PhD in Pharmacology and Toxicology at the Atlantic Veterinary College in Canada. Mathieu is a Diplomate of the European College of Veterinary Pharmacology and Toxicology, a Diplomate of the American College of Veterinary Clinical Pharmacology and holds an Executive MBA from ESCP.
Mathieu has worked for more than 15 years in the veterinary pharmaceuticals industry with various R&D roles of increasing responsibilities, bringing several opportunities from Discovery to Registration. After 10 years in various positions in Novartis Animal Health and Elanco, Mathieu joined Ceva in 2017 and is currently Pharmaceutical Development Director.